Rujipas Sirijatuphat

11PUBLICATIONS
28CO-AUTHORS
Medical bacteriologyGene and molecular therapyEpidemiological methodsInfectious diseasesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 07, 2026
A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.

|Sep 05, 2026
Generic versus branded tigecycline for multidrug-resistant gram-negative bacilli and nontuberculous mycobacterial infections: A comparative safety and efficacy analysis.

|Dec 24, 2025
Correction: Sirijatuphat et al. Distinguishing SARS-CoV-2 Infection and Non-SARS-CoV-2 Viral Infections in Adult Patients through Clinical Score Tools. Trop. Med. Infect. Dis. 2023, 8, 61.

Rujipas Sirijatuphat, Kulprasut Sirianan, Navin Horthongkham

|Nov 07, 2024
Favipiravir pharmacokinetics in Thai adults with mild COVID-19: A sub-study of interpatient variability and ethnic differences in exposure.

Ing-Orn Prasanchaimontri, Weerawat Manosuthi, Henry Pertinez

|Feb 23, 2024
Clinical characteristics and outcomes of acute bacterial meningitis in adults at a tertiary university hospital in Thailand.

Rujipas Sirijatuphat, Attasit Rungrotsakhon, Amornrut Leelaporn

|Jan 20, 2023
Distinguishing SARS-CoV-2 Infection and Non-SARS-CoV-2 Viral Infections in Adult Patients through Clinical Score Tools.

Rujipas Sirijatuphat, Kulprasut Sirianan, Navin Horthongkham

Pageof 2

Frequent Collaborators

1 joint publications

Nasikarn Angkasekwinai

1 joint publications

Visanu Thamlikitkul

1 joint publications

Pinyo Rattanaumpawan

1 joint publications

Ing-Orn Prasanchaimontri